Annotation Detail for FAT3
Basic Information
Top
Pathway ID | Pathway Name |
---|
P00012 | Cadherin signaling pathway |
P00057 | Wnt signaling pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FAT3 mRNA | affects expression | 16483693
|
D001241 |
Aspirin |
Aspirin results in increased expression of FAT3 mRNA | increases expression | 11906190
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.44 | 18287403 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
5.13 | 12372130 20485159 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
4.92 | 15481559 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
3.17 | 15161893 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
3.04 | 12411196 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
2.75 | 17047198 |
MESH:D004487 |
Edema |
|
Aspirin |
4.43 | 17259670 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
4.25 | 12870263 |
MESH:D006261 |
Headache |
|
Aspirin |
6.03 | 15240983 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
6.83 | 15240983 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
4.41 | 15240983 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
3.71 | 12692751 |
MESH:D009325 |
Nausea |
|
Aspirin |
6.28 | 15240983 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
4.32 | 7009135 |
MESH:D010146 |
Pain |
|
Aspirin |
4.28 | 6995502 6363464 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
6.43 | 11156591 |
MESH:D020795 |
Photophobia |
|
Aspirin |
6.83 | 15240983 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
4.88 | 12372130 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
6.03 | 12269725 |
MESH:D020521 |
Stroke |
|
Aspirin |
4.78 | 16403987 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
4.98 | 17672075 |
MESH:D014581 |
Urticaria |
|
Aspirin |
5.04 | 20485159 10982225 |